Approval · Notice of Compliance 5162 · 1994
PENTASA: Notice of Compliance 5162
Issued August 31, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5162
- Date
- August 31, 1994
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Lower gastrointestinal anti-inflammatory
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PENTASA | 02128233 | — |
| PENTASA | 02128241 | — |
| PENTASA | 02128268 | — |
| PENTASA | 02128276 | — |
Medicinal ingredients
- MESALAZINE 1 G per 100ML
- MESALAZINE 2 G per 100ML
- MESALAZINE 4 G per 100ML
- MESALAZINE 1 G per SUP